These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 2060401)
1. [The qualitative and quantitative diagnostic significance of P-VEP in the evaluation of glaucomatous visual function damage]. He ZJ Zhonghua Yan Ke Za Zhi; 1991 Jan; 27(1):25-9. PubMed ID: 2060401 [TBL] [Abstract][Full Text] [Related]
2. The visual evoked potential in glaucoma and ocular hypertension: effects of check size, field size, and stimulation rate. Towle VL; Moskowitz A; Sokol S; Schwartz B Invest Ophthalmol Vis Sci; 1983 Feb; 24(2):175-83. PubMed ID: 6826322 [TBL] [Abstract][Full Text] [Related]
3. Comparing multifocal VEP and standard automated perimetry in high-risk ocular hypertension and early glaucoma. Fortune B; Demirel S; Zhang X; Hood DC; Patterson E; Jamil A; Mansberger SL; Cioffi GA; Johnson CA Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1173-80. PubMed ID: 17325161 [TBL] [Abstract][Full Text] [Related]
4. Sensitivity and specificity of short-duration transient visual evoked potentials (SD-tVEP) in discriminating normal from glaucomatous eyes. Pillai C; Ritch R; Derr P; Gonzalez A; Kopko Cox L; Siegfried J; Liebmann JM; Tello C Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2847-52. PubMed ID: 23513061 [TBL] [Abstract][Full Text] [Related]
5. [Changes of color pattern reversal visual evoked potential of primary glaucoma]. Wang PB; Tong Y; Xia ZH; Tan Q; Xia XB Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 33(9):821-5. PubMed ID: 18812661 [TBL] [Abstract][Full Text] [Related]
6. A comparison between multifocal and conventional VEP latency changes secondary to glaucomatous damage. Grippo TM; Hood DC; Kanadani FN; Ezon I; Greenstein VC; Liebmann JM; Ritch R Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5331-6. PubMed ID: 17122121 [TBL] [Abstract][Full Text] [Related]
7. Clinical ability of pattern electroretinograms and visual evoked potentials in detecting visual dysfunction in ocular hypertension and glaucoma. Parisi V; Miglior S; Manni G; Centofanti M; Bucci MG Ophthalmology; 2006 Feb; 113(2):216-28. PubMed ID: 16406535 [TBL] [Abstract][Full Text] [Related]
8. Spatial modulation transfer function of vision by pattern visual-evoked potentials in patients with early glaucoma. Abe H; Hasegawa S; Takagi M; Yoshizawa T; Usui T Ann Ophthalmol; 1993 Oct; 25(10):364-9. PubMed ID: 8304686 [TBL] [Abstract][Full Text] [Related]
9. Comparison of visual evoked potentials, automated perimetry and frequency-doubling perimetry in early detection of glaucomatous visual field loss. Sarić D; Mandić Z; Iveković R; Geber MZ; Benić G; Tomić Z; Grgić D Coll Antropol; 2005; 29 Suppl 1():111-3. PubMed ID: 16193690 [TBL] [Abstract][Full Text] [Related]
10. Assessment of visual evoked response in chronic simple glaucoma. Sood NN; Basumatary P; Agarwal HC Indian J Ophthalmol; 1987; 35(5-6):274-7. PubMed ID: 3508790 [TBL] [Abstract][Full Text] [Related]
11. Detecting early functional damage in glaucoma suspect and ocular hypertensive patients with the multifocal VEP technique. Thienprasiddhi P; Greenstein VC; Chu DH; Xu L; Liebmann JM; Ritch R; Hood DC J Glaucoma; 2006 Aug; 15(4):321-7. PubMed ID: 16865010 [TBL] [Abstract][Full Text] [Related]
12. Mapping of glaucomatous visual field defects by multifocal VEPs. Hasegawa S; Abe H Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3341-8. PubMed ID: 11726643 [TBL] [Abstract][Full Text] [Related]
13. Visual function-specific perimetry for indirect comparison of different ganglion cell populations in glaucoma. Sample PA; Bosworth CF; Blumenthal EZ; Girkin C; Weinreb RN Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1783-90. PubMed ID: 10845599 [TBL] [Abstract][Full Text] [Related]
14. Multifocal blue-on-yellow visual evoked potentials in early glaucoma. Klistorner A; Graham SL; Martins A; Grigg JR; Arvind H; Kumar RS; James AC; Billson FA Ophthalmology; 2007 Sep; 114(9):1613-21. PubMed ID: 17822971 [TBL] [Abstract][Full Text] [Related]
15. Monitoring glaucoma progression with visual evoked potentials of the blue-sensitive pathway. Horn FK; Jonas JB; Budde WM; Jünemann AM; Mardin CY; Korth M Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1828-34. PubMed ID: 12036986 [TBL] [Abstract][Full Text] [Related]
17. Multivariate approach for quantification of morphologic and functional damage in glaucoma. Martus P; Jünemann A; Wisse M; Budde WM; Horn F; Korth M; Jonas JB Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1099-110. PubMed ID: 10752947 [TBL] [Abstract][Full Text] [Related]
18. [Changes in PVEP in primary open angle glaucoma and analysis of the waveform index]. Pang L; Li MY Zhonghua Yan Ke Za Zhi; 1992 Sep; 28(5):282-6. PubMed ID: 1299582 [TBL] [Abstract][Full Text] [Related]
19. Oral citicoline treatment improves visual pathway function in glaucoma. Rejdak R; Toczołowski J; Kurkowski J; Kamiński ML; Rejdak K; Stelmasiak Z; Grieb P Med Sci Monit; 2003 Mar; 9(3):PI24-8. PubMed ID: 12640353 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic capability of optical coherence tomography in evaluating the degree of glaucomatous retinal nerve fiber damage. Sihota R; Sony P; Gupta V; Dada T; Singh R Invest Ophthalmol Vis Sci; 2006 May; 47(5):2006-10. PubMed ID: 16639009 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]